The global High Throughput Screening Market size is expected
to generate a revenue of USD 30.91 billion by 2025, according to a new report
by Grand View Research, Inc., exhibiting a CAGR of 7.89% during the forecast
period. Increasing adoption of faster and accurate technology by pharmaceutical
companies to introduce newer molecules in the market is anticipated to provide
a significant push to the market.
High throughput screening is used for testing of molecules
in development phase on various grounds such as chemical, pharmaceutical, and
genetic reactions. These screenings help in drug design and development based
on real time results and near natural conditions that mimic natural reactions
between the molecule and the body.
Moreover, this method can be fully automated using required
hardware and software capable of handling a fully automated process along with
data storage units that store and process considerable amount of data in short
span of time.
As of 2016, approximately 55.0% of high throughput screening
tests are carried out based on the cell based assays. Cell based assays are
used majorly owing to the results that can be obtained at cellular levels along
with pathways and mechanism.
These assays range from cytotoxic tests, including
apoptosis, to cell metabolic assays. One more major technology implantation is
the introduction of 3D – cell culture, which can help mimic natural conditions
that give more accurate results and reactions to tests carried on. This trend
is estimated to support the growth of the market during the forecast period.
Browse Details of Report @ https://www.grandviewresearch.com/industry-analysis/medical-document-management-systems-market
Further Key Findings from the Report Suggest:
- The
market is driven by increasing competition between pharmaceutical
companies to introduce novel molecules
- Emerging
3D cell culture technology that provides better results in real time is
set to boost the market
- North
America emerged as the clear hotspot for the development and adoption of
this technology and had a major share in the market
- Emerging
regions such as Asia Pacific and Latin America are set to witness
considerable growth in demand over the forecast period driven by the need
of newer molecules to cure various diseases
- Some
of the key players in this market are Agilent Technologies, Inc., Danaher
Corporation, Thermofisher Scientific, Inc., PerkinElmer, Inc. and Tecan
Group Ltd., Merck Millipore, Bio-Rad laboratories, Hamilton Company, Axxam
S.p.A., and Aurora Biomed.
About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment